Cargando…
Blood, Blood Components, Plasma, and Plasma Products
This review of the 2013–2014 publications on important side effects of blood, blood components, plasma, and plasma products covers albumin, blood transfusion (erythrocytes, granulocytes, and platelets), blood substitutes (hemoglobin-based oxygen carriers), plasma products (alpha1-antitrypsin, C1 est...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148777/ http://dx.doi.org/10.1016/bs.seda.2015.05.003 |
_version_ | 1783520666586185728 |
---|---|
author | Opsha, Yekaterina Brophy, Alison |
author_facet | Opsha, Yekaterina Brophy, Alison |
author_sort | Opsha, Yekaterina |
collection | PubMed |
description | This review of the 2013–2014 publications on important side effects of blood, blood components, plasma, and plasma products covers albumin, blood transfusion (erythrocytes, granulocytes, and platelets), blood substitutes (hemoglobin-based oxygen carriers), plasma products (alpha1-antitrypsin, C1 esterase inhibitor concentrate, cryoprecipitate, and fresh frozen plasma), plasma substitutes (dextrans, etherified starches, and gelatin), globulins (intravenous immunoglobulin, subcutaneous immunoglobulin, and Anti-D immunoglobulin), coagulation proteins (factor I, factor II, factor VIIa, factor VIII, factor IX, prothrombin complex concentrate, and von Willebrand factor/factor VIII concentrates), erythropoietin and derivatives, thrombopoietin and receptor agonists, transmission of infectious agents through blood donation, and stem cells. This chapter includes blood products for which hemovigilance is in force, and allows the reader to stay up to date on newly recognized and published data in the blood product arena. Since blood and plasma products are available through blood donation, prevention of transmitted infections is of extreme importance and is also discussed here. |
format | Online Article Text |
id | pubmed-7148777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71487772020-04-13 Blood, Blood Components, Plasma, and Plasma Products Opsha, Yekaterina Brophy, Alison Side Effects of Drugs Annual Article This review of the 2013–2014 publications on important side effects of blood, blood components, plasma, and plasma products covers albumin, blood transfusion (erythrocytes, granulocytes, and platelets), blood substitutes (hemoglobin-based oxygen carriers), plasma products (alpha1-antitrypsin, C1 esterase inhibitor concentrate, cryoprecipitate, and fresh frozen plasma), plasma substitutes (dextrans, etherified starches, and gelatin), globulins (intravenous immunoglobulin, subcutaneous immunoglobulin, and Anti-D immunoglobulin), coagulation proteins (factor I, factor II, factor VIIa, factor VIII, factor IX, prothrombin complex concentrate, and von Willebrand factor/factor VIII concentrates), erythropoietin and derivatives, thrombopoietin and receptor agonists, transmission of infectious agents through blood donation, and stem cells. This chapter includes blood products for which hemovigilance is in force, and allows the reader to stay up to date on newly recognized and published data in the blood product arena. Since blood and plasma products are available through blood donation, prevention of transmitted infections is of extreme importance and is also discussed here. Elsevier B.V. 2015 2015-07-26 /pmc/articles/PMC7148777/ http://dx.doi.org/10.1016/bs.seda.2015.05.003 Text en Copyright © 2015 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Opsha, Yekaterina Brophy, Alison Blood, Blood Components, Plasma, and Plasma Products |
title | Blood, Blood Components, Plasma, and Plasma Products |
title_full | Blood, Blood Components, Plasma, and Plasma Products |
title_fullStr | Blood, Blood Components, Plasma, and Plasma Products |
title_full_unstemmed | Blood, Blood Components, Plasma, and Plasma Products |
title_short | Blood, Blood Components, Plasma, and Plasma Products |
title_sort | blood, blood components, plasma, and plasma products |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148777/ http://dx.doi.org/10.1016/bs.seda.2015.05.003 |
work_keys_str_mv | AT opshayekaterina bloodbloodcomponentsplasmaandplasmaproducts AT brophyalison bloodbloodcomponentsplasmaandplasmaproducts |